nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Urinary retention—Valrubicin—urinary bladder cancer	0.0248	0.0261	CcSEcCtD
Levorphanol—Injection site reaction—Mitomycin—urinary bladder cancer	0.0246	0.0259	CcSEcCtD
Levorphanol—Morphine—UGT2B7—urinary bladder cancer	0.0226	0.449	CrCbGaD
Levorphanol—Dysuria—Valrubicin—urinary bladder cancer	0.0211	0.0222	CcSEcCtD
Levorphanol—Hypoxia—Thiotepa—urinary bladder cancer	0.0196	0.0206	CcSEcCtD
Levorphanol—Hypoxia—Gemcitabine—urinary bladder cancer	0.0165	0.0174	CcSEcCtD
Levorphanol—Renal failure—Mitomycin—urinary bladder cancer	0.0136	0.0143	CcSEcCtD
Levorphanol—Cyanosis—Etoposide—urinary bladder cancer	0.0126	0.0133	CcSEcCtD
Levorphanol—Respiratory failure—Gemcitabine—urinary bladder cancer	0.0107	0.0112	CcSEcCtD
Levorphanol—Feeling abnormal—Valrubicin—urinary bladder cancer	0.0106	0.0111	CcSEcCtD
Levorphanol—Apnoea—Etoposide—urinary bladder cancer	0.0106	0.0111	CcSEcCtD
Levorphanol—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.0105	0.011	CcSEcCtD
Levorphanol—Injection site reaction—Gemcitabine—urinary bladder cancer	0.0104	0.011	CcSEcCtD
Levorphanol—Abdominal pain—Valrubicin—urinary bladder cancer	0.0101	0.0107	CcSEcCtD
Levorphanol—Estrone—ESR2—urinary bladder cancer	0.00975	0.194	CrCbGaD
Levorphanol—Coma—Fluorouracil—urinary bladder cancer	0.00941	0.00991	CcSEcCtD
Levorphanol—Pruritus—Valrubicin—urinary bladder cancer	0.00907	0.00955	CcSEcCtD
Levorphanol—Confusional state—Mitomycin—urinary bladder cancer	0.00891	0.00938	CcSEcCtD
Levorphanol—Shock—Mitomycin—urinary bladder cancer	0.00869	0.00915	CcSEcCtD
Levorphanol—Urinary retention—Thiotepa—urinary bladder cancer	0.0086	0.00905	CcSEcCtD
Levorphanol—Cardiac arrest—Thiotepa—urinary bladder cancer	0.0086	0.00905	CcSEcCtD
Levorphanol—Dizziness—Valrubicin—urinary bladder cancer	0.00848	0.00893	CcSEcCtD
Levorphanol—Hypoxia—Methotrexate—urinary bladder cancer	0.00843	0.00888	CcSEcCtD
Levorphanol—Vomiting—Valrubicin—urinary bladder cancer	0.00815	0.00858	CcSEcCtD
Levorphanol—Rash—Valrubicin—urinary bladder cancer	0.00809	0.00851	CcSEcCtD
Levorphanol—Dermatitis—Valrubicin—urinary bladder cancer	0.00808	0.00851	CcSEcCtD
Levorphanol—Amnesia—Fluorouracil—urinary bladder cancer	0.00796	0.00838	CcSEcCtD
Levorphanol—Lethargy—Fluorouracil—urinary bladder cancer	0.00763	0.00803	CcSEcCtD
Levorphanol—Nausea—Valrubicin—urinary bladder cancer	0.00762	0.00802	CcSEcCtD
Levorphanol—Cyanosis—Methotrexate—urinary bladder cancer	0.00757	0.00797	CcSEcCtD
Levorphanol—Amnesia—Cisplatin—urinary bladder cancer	0.00754	0.00794	CcSEcCtD
Levorphanol—Hypokinesia—Epirubicin—urinary bladder cancer	0.00743	0.00782	CcSEcCtD
Levorphanol—Estradiol—ESR2—urinary bladder cancer	0.00739	0.147	CrCbGaD
Levorphanol—Dysuria—Thiotepa—urinary bladder cancer	0.00731	0.00769	CcSEcCtD
Levorphanol—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00728	0.00767	CcSEcCtD
Levorphanol—Cardiac arrest—Fluorouracil—urinary bladder cancer	0.00711	0.00749	CcSEcCtD
Levorphanol—Hypokinesia—Doxorubicin—urinary bladder cancer	0.00687	0.00724	CcSEcCtD
Levorphanol—Renal failure—Thiotepa—urinary bladder cancer	0.00685	0.00721	CcSEcCtD
Levorphanol—Apnoea—Methotrexate—urinary bladder cancer	0.00632	0.00666	CcSEcCtD
Levorphanol—Cardiac arrest—Etoposide—urinary bladder cancer	0.00617	0.0065	CcSEcCtD
Levorphanol—Estrone—ESR1—urinary bladder cancer	0.00601	0.119	CrCbGaD
Levorphanol—Dizziness—Mitomycin—urinary bladder cancer	0.00584	0.00615	CcSEcCtD
Levorphanol—Renal failure—Gemcitabine—urinary bladder cancer	0.00576	0.00607	CcSEcCtD
Levorphanol—Sweating—Gemcitabine—urinary bladder cancer	0.00562	0.00592	CcSEcCtD
Levorphanol—Vomiting—Mitomycin—urinary bladder cancer	0.00562	0.00591	CcSEcCtD
Levorphanol—Arrhythmia—Thiotepa—urinary bladder cancer	0.00559	0.00588	CcSEcCtD
Levorphanol—Rash—Mitomycin—urinary bladder cancer	0.00557	0.00587	CcSEcCtD
Levorphanol—Dermatitis—Mitomycin—urinary bladder cancer	0.00556	0.00586	CcSEcCtD
Levorphanol—Thinking abnormal—Epirubicin—urinary bladder cancer	0.00548	0.00577	CcSEcCtD
Levorphanol—Respiratory failure—Methotrexate—urinary bladder cancer	0.00546	0.00574	CcSEcCtD
Levorphanol—Renal failure—Cisplatin—urinary bladder cancer	0.00537	0.00565	CcSEcCtD
Levorphanol—Tension—Thiotepa—urinary bladder cancer	0.00534	0.00562	CcSEcCtD
Levorphanol—Dyskinesia—Epirubicin—urinary bladder cancer	0.00534	0.00562	CcSEcCtD
Levorphanol—Nervousness—Thiotepa—urinary bladder cancer	0.00529	0.00557	CcSEcCtD
Levorphanol—Nausea—Mitomycin—urinary bladder cancer	0.00525	0.00553	CcSEcCtD
Levorphanol—Thinking abnormal—Doxorubicin—urinary bladder cancer	0.00507	0.00534	CcSEcCtD
Levorphanol—Agitation—Thiotepa—urinary bladder cancer	0.005	0.00527	CcSEcCtD
Levorphanol—Bradycardia—Cisplatin—urinary bladder cancer	0.00499	0.00526	CcSEcCtD
Levorphanol—Injection site reaction—Epirubicin—urinary bladder cancer	0.00498	0.00525	CcSEcCtD
Levorphanol—Abnormal dreams—Epirubicin—urinary bladder cancer	0.00496	0.00522	CcSEcCtD
Levorphanol—Dyskinesia—Doxorubicin—urinary bladder cancer	0.00494	0.0052	CcSEcCtD
Levorphanol—Renal failure—Etoposide—urinary bladder cancer	0.00492	0.00518	CcSEcCtD
Levorphanol—Coma—Methotrexate—urinary bladder cancer	0.0049	0.00515	CcSEcCtD
Levorphanol—Visual impairment—Cisplatin—urinary bladder cancer	0.00473	0.00498	CcSEcCtD
Levorphanol—Convulsion—Thiotepa—urinary bladder cancer	0.00472	0.00497	CcSEcCtD
Levorphanol—Arrhythmia—Gemcitabine—urinary bladder cancer	0.0047	0.00495	CcSEcCtD
Levorphanol—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00462	0.00487	CcSEcCtD
Levorphanol—Injection site reaction—Doxorubicin—urinary bladder cancer	0.00461	0.00486	CcSEcCtD
Levorphanol—Abnormal dreams—Doxorubicin—urinary bladder cancer	0.00458	0.00483	CcSEcCtD
Levorphanol—Coma—Epirubicin—urinary bladder cancer	0.00458	0.00482	CcSEcCtD
Levorphanol—Estradiol—ESR1—urinary bladder cancer	0.00455	0.0905	CrCbGaD
Levorphanol—Flushing—Cisplatin—urinary bladder cancer	0.00455	0.00479	CcSEcCtD
Levorphanol—Confusional state—Thiotepa—urinary bladder cancer	0.00448	0.00472	CcSEcCtD
Levorphanol—Arrhythmia—Cisplatin—urinary bladder cancer	0.00438	0.00461	CcSEcCtD
Levorphanol—Abnormal vision—Epirubicin—urinary bladder cancer	0.00437	0.0046	CcSEcCtD
Levorphanol—Mental disability—Epirubicin—urinary bladder cancer	0.00435	0.00458	CcSEcCtD
Levorphanol—Tachycardia—Thiotepa—urinary bladder cancer	0.00434	0.00457	CcSEcCtD
Levorphanol—Coma—Doxorubicin—urinary bladder cancer	0.00424	0.00446	CcSEcCtD
Levorphanol—Flushing—Etoposide—urinary bladder cancer	0.00417	0.00439	CcSEcCtD
Levorphanol—Muscle spasms—Cisplatin—urinary bladder cancer	0.0041	0.00432	CcSEcCtD
Levorphanol—Abnormal vision—Doxorubicin—urinary bladder cancer	0.00405	0.00426	CcSEcCtD
Levorphanol—Mental disability—Doxorubicin—urinary bladder cancer	0.00403	0.00424	CcSEcCtD
Levorphanol—Lethargy—Methotrexate—urinary bladder cancer	0.00397	0.00418	CcSEcCtD
Levorphanol—Dyspepsia—Thiotepa—urinary bladder cancer	0.00391	0.00412	CcSEcCtD
Levorphanol—Convulsion—Fluorouracil—urinary bladder cancer	0.0039	0.00411	CcSEcCtD
Levorphanol—Constipation—Thiotepa—urinary bladder cancer	0.0038	0.004	CcSEcCtD
Levorphanol—Muscle spasms—Etoposide—urinary bladder cancer	0.00376	0.00396	CcSEcCtD
Levorphanol—Lethargy—Epirubicin—urinary bladder cancer	0.00371	0.00391	CcSEcCtD
Levorphanol—Confusional state—Fluorouracil—urinary bladder cancer	0.00371	0.0039	CcSEcCtD
Levorphanol—Convulsion—Cisplatin—urinary bladder cancer	0.0037	0.00389	CcSEcCtD
Levorphanol—Mood swings—Methotrexate—urinary bladder cancer	0.00368	0.00388	CcSEcCtD
Levorphanol—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00366	0.00385	CcSEcCtD
Levorphanol—Diplopia—Epirubicin—urinary bladder cancer	0.00364	0.00383	CcSEcCtD
Levorphanol—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00363	0.00383	CcSEcCtD
Levorphanol—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00361	0.0038	CcSEcCtD
Levorphanol—Tachycardia—Fluorouracil—urinary bladder cancer	0.00359	0.00378	CcSEcCtD
Levorphanol—Affect lability—Epirubicin—urinary bladder cancer	0.00358	0.00377	CcSEcCtD
Levorphanol—Urticaria—Thiotepa—urinary bladder cancer	0.00353	0.00372	CcSEcCtD
Levorphanol—Abdominal pain—Thiotepa—urinary bladder cancer	0.00351	0.0037	CcSEcCtD
Levorphanol—Hypotension—Gemcitabine—urinary bladder cancer	0.00349	0.00368	CcSEcCtD
Levorphanol—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00346	0.00364	CcSEcCtD
Levorphanol—Mood swings—Epirubicin—urinary bladder cancer	0.00345	0.00363	CcSEcCtD
Levorphanol—Lethargy—Doxorubicin—urinary bladder cancer	0.00344	0.00362	CcSEcCtD
Levorphanol—Hypotension—Fluorouracil—urinary bladder cancer	0.00343	0.00362	CcSEcCtD
Levorphanol—Tachycardia—Cisplatin—urinary bladder cancer	0.0034	0.00358	CcSEcCtD
Levorphanol—Convulsion—Etoposide—urinary bladder cancer	0.00339	0.00357	CcSEcCtD
Levorphanol—Insomnia—Gemcitabine—urinary bladder cancer	0.00338	0.00356	CcSEcCtD
Levorphanol—Diplopia—Doxorubicin—urinary bladder cancer	0.00337	0.00355	CcSEcCtD
Levorphanol—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00337	0.00355	CcSEcCtD
Levorphanol—Insomnia—Fluorouracil—urinary bladder cancer	0.00332	0.0035	CcSEcCtD
Levorphanol—Affect lability—Doxorubicin—urinary bladder cancer	0.00331	0.00349	CcSEcCtD
Levorphanol—Hypotension—Cisplatin—urinary bladder cancer	0.00325	0.00343	CcSEcCtD
Levorphanol—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00323	0.00341	CcSEcCtD
Levorphanol—Confusional state—Etoposide—urinary bladder cancer	0.00322	0.00339	CcSEcCtD
Levorphanol—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.0032	0.00337	CcSEcCtD
Levorphanol—Constipation—Gemcitabine—urinary bladder cancer	0.0032	0.00337	CcSEcCtD
Levorphanol—Mood swings—Doxorubicin—urinary bladder cancer	0.00319	0.00336	CcSEcCtD
Levorphanol—Dysuria—Methotrexate—urinary bladder cancer	0.00314	0.00331	CcSEcCtD
Levorphanol—Pruritus—Thiotepa—urinary bladder cancer	0.00314	0.00331	CcSEcCtD
Levorphanol—Tachycardia—Etoposide—urinary bladder cancer	0.00311	0.00328	CcSEcCtD
Levorphanol—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00309	0.00325	CcSEcCtD
Levorphanol—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00308	0.00324	CcSEcCtD
Levorphanol—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00303	0.00319	CcSEcCtD
Levorphanol—Hypotension—Etoposide—urinary bladder cancer	0.00298	0.00314	CcSEcCtD
Levorphanol—Renal failure—Methotrexate—urinary bladder cancer	0.00295	0.0031	CcSEcCtD
Levorphanol—Dysuria—Epirubicin—urinary bladder cancer	0.00294	0.0031	CcSEcCtD
Levorphanol—Dizziness—Thiotepa—urinary bladder cancer	0.00294	0.00309	CcSEcCtD
Levorphanol—Urticaria—Fluorouracil—urinary bladder cancer	0.00292	0.00307	CcSEcCtD
Levorphanol—Sweating—Methotrexate—urinary bladder cancer	0.00287	0.00303	CcSEcCtD
Levorphanol—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00287	0.00302	CcSEcCtD
Levorphanol—Vomiting—Thiotepa—urinary bladder cancer	0.00282	0.00297	CcSEcCtD
Levorphanol—Rash—Thiotepa—urinary bladder cancer	0.0028	0.00295	CcSEcCtD
Levorphanol—Dermatitis—Thiotepa—urinary bladder cancer	0.0028	0.00295	CcSEcCtD
Levorphanol—Renal failure—Epirubicin—urinary bladder cancer	0.00276	0.0029	CcSEcCtD
Levorphanol—Constipation—Etoposide—urinary bladder cancer	0.00273	0.00287	CcSEcCtD
Levorphanol—Dysuria—Doxorubicin—urinary bladder cancer	0.00272	0.00287	CcSEcCtD
Levorphanol—Sweating—Epirubicin—urinary bladder cancer	0.00269	0.00283	CcSEcCtD
Levorphanol—Pruritus—Gemcitabine—urinary bladder cancer	0.00264	0.00278	CcSEcCtD
Levorphanol—Nausea—Thiotepa—urinary bladder cancer	0.00264	0.00278	CcSEcCtD
Levorphanol—Feeling abnormal—Etoposide—urinary bladder cancer	0.00263	0.00277	CcSEcCtD
Levorphanol—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00261	0.00275	CcSEcCtD
Levorphanol—Pruritus—Fluorouracil—urinary bladder cancer	0.0026	0.00274	CcSEcCtD
Levorphanol—Visual impairment—Methotrexate—urinary bladder cancer	0.00259	0.00273	CcSEcCtD
Levorphanol—Bradycardia—Epirubicin—urinary bladder cancer	0.00256	0.0027	CcSEcCtD
Levorphanol—Renal failure—Doxorubicin—urinary bladder cancer	0.00255	0.00269	CcSEcCtD
Levorphanol—Urticaria—Etoposide—urinary bladder cancer	0.00254	0.00267	CcSEcCtD
Levorphanol—Abdominal pain—Etoposide—urinary bladder cancer	0.00252	0.00266	CcSEcCtD
Levorphanol—Sweating—Doxorubicin—urinary bladder cancer	0.00249	0.00262	CcSEcCtD
Levorphanol—Dizziness—Fluorouracil—urinary bladder cancer	0.00243	0.00256	CcSEcCtD
Levorphanol—Visual impairment—Epirubicin—urinary bladder cancer	0.00243	0.00255	CcSEcCtD
Levorphanol—Vomiting—Gemcitabine—urinary bladder cancer	0.00238	0.0025	CcSEcCtD
Levorphanol—Bradycardia—Doxorubicin—urinary bladder cancer	0.00237	0.0025	CcSEcCtD
Levorphanol—Rash—Gemcitabine—urinary bladder cancer	0.00236	0.00248	CcSEcCtD
Levorphanol—Dermatitis—Gemcitabine—urinary bladder cancer	0.00235	0.00248	CcSEcCtD
Levorphanol—Flushing—Epirubicin—urinary bladder cancer	0.00234	0.00246	CcSEcCtD
Levorphanol—Vomiting—Fluorouracil—urinary bladder cancer	0.00234	0.00246	CcSEcCtD
Levorphanol—Rash—Fluorouracil—urinary bladder cancer	0.00232	0.00244	CcSEcCtD
Levorphanol—Dermatitis—Fluorouracil—urinary bladder cancer	0.00231	0.00244	CcSEcCtD
Levorphanol—Pruritus—Etoposide—urinary bladder cancer	0.00226	0.00238	CcSEcCtD
Levorphanol—Arrhythmia—Epirubicin—urinary bladder cancer	0.00225	0.00237	CcSEcCtD
Levorphanol—Visual impairment—Doxorubicin—urinary bladder cancer	0.00225	0.00236	CcSEcCtD
Levorphanol—Nausea—Gemcitabine—urinary bladder cancer	0.00222	0.00234	CcSEcCtD
Levorphanol—Vomiting—Cisplatin—urinary bladder cancer	0.00221	0.00233	CcSEcCtD
Levorphanol—Rash—Cisplatin—urinary bladder cancer	0.0022	0.00231	CcSEcCtD
Levorphanol—Dermatitis—Cisplatin—urinary bladder cancer	0.00219	0.00231	CcSEcCtD
Levorphanol—Nausea—Fluorouracil—urinary bladder cancer	0.00218	0.0023	CcSEcCtD
Levorphanol—Flushing—Doxorubicin—urinary bladder cancer	0.00216	0.00228	CcSEcCtD
Levorphanol—Tension—Epirubicin—urinary bladder cancer	0.00215	0.00226	CcSEcCtD
Levorphanol—Nervousness—Epirubicin—urinary bladder cancer	0.00213	0.00224	CcSEcCtD
Levorphanol—Dizziness—Etoposide—urinary bladder cancer	0.00211	0.00222	CcSEcCtD
Levorphanol—Muscle spasms—Epirubicin—urinary bladder cancer	0.00211	0.00222	CcSEcCtD
Levorphanol—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00208	0.00219	CcSEcCtD
Levorphanol—Nausea—Cisplatin—urinary bladder cancer	0.00207	0.00218	CcSEcCtD
Levorphanol—Convulsion—Methotrexate—urinary bladder cancer	0.00203	0.00214	CcSEcCtD
Levorphanol—Vomiting—Etoposide—urinary bladder cancer	0.00203	0.00214	CcSEcCtD
Levorphanol—Agitation—Epirubicin—urinary bladder cancer	0.00201	0.00212	CcSEcCtD
Levorphanol—Rash—Etoposide—urinary bladder cancer	0.00201	0.00212	CcSEcCtD
Levorphanol—Dermatitis—Etoposide—urinary bladder cancer	0.00201	0.00212	CcSEcCtD
Levorphanol—Tension—Doxorubicin—urinary bladder cancer	0.00199	0.0021	CcSEcCtD
Levorphanol—Nervousness—Doxorubicin—urinary bladder cancer	0.00197	0.00207	CcSEcCtD
Levorphanol—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00195	0.00205	CcSEcCtD
Levorphanol—Palpitations—Epirubicin—urinary bladder cancer	0.00194	0.00204	CcSEcCtD
Levorphanol—Confusional state—Methotrexate—urinary bladder cancer	0.00193	0.00203	CcSEcCtD
Levorphanol—Convulsion—Epirubicin—urinary bladder cancer	0.0019	0.002	CcSEcCtD
Levorphanol—Nausea—Etoposide—urinary bladder cancer	0.0019	0.002	CcSEcCtD
Levorphanol—Agitation—Doxorubicin—urinary bladder cancer	0.00186	0.00196	CcSEcCtD
Levorphanol—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00185	0.00195	CcSEcCtD
Levorphanol—Dry mouth—Epirubicin—urinary bladder cancer	0.00182	0.00192	CcSEcCtD
Levorphanol—Confusional state—Epirubicin—urinary bladder cancer	0.0018	0.0019	CcSEcCtD
Levorphanol—Palpitations—Doxorubicin—urinary bladder cancer	0.00179	0.00189	CcSEcCtD
Levorphanol—Hypotension—Methotrexate—urinary bladder cancer	0.00179	0.00188	CcSEcCtD
Levorphanol—Shock—Epirubicin—urinary bladder cancer	0.00176	0.00185	CcSEcCtD
Levorphanol—Convulsion—Doxorubicin—urinary bladder cancer	0.00176	0.00185	CcSEcCtD
Levorphanol—Tachycardia—Epirubicin—urinary bladder cancer	0.00175	0.00184	CcSEcCtD
Levorphanol—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00173	0.00182	CcSEcCtD
Levorphanol—Insomnia—Methotrexate—urinary bladder cancer	0.00173	0.00182	CcSEcCtD
Levorphanol—Dry mouth—Doxorubicin—urinary bladder cancer	0.00169	0.00178	CcSEcCtD
Levorphanol—Dyspepsia—Methotrexate—urinary bladder cancer	0.00168	0.00177	CcSEcCtD
Levorphanol—Hypotension—Epirubicin—urinary bladder cancer	0.00167	0.00176	CcSEcCtD
Levorphanol—Confusional state—Doxorubicin—urinary bladder cancer	0.00167	0.00176	CcSEcCtD
Levorphanol—Shock—Doxorubicin—urinary bladder cancer	0.00163	0.00171	CcSEcCtD
Levorphanol—Insomnia—Epirubicin—urinary bladder cancer	0.00162	0.0017	CcSEcCtD
Levorphanol—Tachycardia—Doxorubicin—urinary bladder cancer	0.00162	0.0017	CcSEcCtD
Levorphanol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.0016	0.00168	CcSEcCtD
Levorphanol—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00158	0.00166	CcSEcCtD
Levorphanol—Dyspepsia—Epirubicin—urinary bladder cancer	0.00157	0.00166	CcSEcCtD
Levorphanol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00156	0.00165	CcSEcCtD
Levorphanol—Hypotension—Doxorubicin—urinary bladder cancer	0.00155	0.00163	CcSEcCtD
Levorphanol—Constipation—Epirubicin—urinary bladder cancer	0.00153	0.00161	CcSEcCtD
Levorphanol—Urticaria—Methotrexate—urinary bladder cancer	0.00152	0.0016	CcSEcCtD
Levorphanol—Abdominal pain—Methotrexate—urinary bladder cancer	0.00151	0.00159	CcSEcCtD
Levorphanol—Insomnia—Doxorubicin—urinary bladder cancer	0.0015	0.00158	CcSEcCtD
Levorphanol—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00147	0.00155	CcSEcCtD
Levorphanol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00146	0.00154	CcSEcCtD
Levorphanol—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00146	0.00153	CcSEcCtD
Levorphanol—Urticaria—Epirubicin—urinary bladder cancer	0.00142	0.0015	CcSEcCtD
Levorphanol—Constipation—Doxorubicin—urinary bladder cancer	0.00142	0.00149	CcSEcCtD
Levorphanol—Abdominal pain—Epirubicin—urinary bladder cancer	0.00141	0.00149	CcSEcCtD
Levorphanol—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00136	0.00144	CcSEcCtD
Levorphanol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00135	0.00143	CcSEcCtD
Levorphanol—Pruritus—Methotrexate—urinary bladder cancer	0.00135	0.00142	CcSEcCtD
Levorphanol—Urticaria—Doxorubicin—urinary bladder cancer	0.00131	0.00138	CcSEcCtD
Levorphanol—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00131	0.00138	CcSEcCtD
Levorphanol—Pruritus—Epirubicin—urinary bladder cancer	0.00127	0.00133	CcSEcCtD
Levorphanol—Dizziness—Methotrexate—urinary bladder cancer	0.00126	0.00133	CcSEcCtD
Levorphanol—Vomiting—Methotrexate—urinary bladder cancer	0.00122	0.00128	CcSEcCtD
Levorphanol—Rash—Methotrexate—urinary bladder cancer	0.00121	0.00127	CcSEcCtD
Levorphanol—Dermatitis—Methotrexate—urinary bladder cancer	0.0012	0.00127	CcSEcCtD
Levorphanol—Dizziness—Epirubicin—urinary bladder cancer	0.00118	0.00125	CcSEcCtD
Levorphanol—Pruritus—Doxorubicin—urinary bladder cancer	0.00117	0.00123	CcSEcCtD
Levorphanol—Vomiting—Epirubicin—urinary bladder cancer	0.00114	0.0012	CcSEcCtD
Levorphanol—Nausea—Methotrexate—urinary bladder cancer	0.00114	0.0012	CcSEcCtD
Levorphanol—Rash—Epirubicin—urinary bladder cancer	0.00113	0.00119	CcSEcCtD
Levorphanol—Dermatitis—Epirubicin—urinary bladder cancer	0.00113	0.00119	CcSEcCtD
Levorphanol—Dizziness—Doxorubicin—urinary bladder cancer	0.00109	0.00115	CcSEcCtD
Levorphanol—Nausea—Epirubicin—urinary bladder cancer	0.00106	0.00112	CcSEcCtD
Levorphanol—Vomiting—Doxorubicin—urinary bladder cancer	0.00105	0.00111	CcSEcCtD
Levorphanol—Rash—Doxorubicin—urinary bladder cancer	0.00104	0.0011	CcSEcCtD
Levorphanol—Dermatitis—Doxorubicin—urinary bladder cancer	0.00104	0.0011	CcSEcCtD
Levorphanol—Nausea—Doxorubicin—urinary bladder cancer	0.000983	0.00104	CcSEcCtD
